Singapore markets close in 1 hour 11 minutes
Straits Times Index
3,173.16 -14.50 (-0.45%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,222.10 -163.77 (-1.00%) FTSE 100
7,826.26 -50.79 (-0.64%) Bitcoin USD
64,568.63 +3,362.79 (+5.49%) CMC Crypto 200
1,324.65 +12.03 (+0.92%)
AZN Jan 2025 65.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:53PM EDT. Market open.
Loading interactive chart…
- Zacks
Astrazeneca (AZN) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it takes? Let's find out.
- Business Wire
IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
WILMINGTON, Del., April 16, 2024--Updated exploratory results from the TOPAZ-1 Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care chemotherapy demonstrated a clinically meaningful long-term overall survival (OS) benefit at three years for patients with advanced biliary tract cancer (BTC).
- Zacks
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
The FDA approves AstraZeneca's (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11 years.
© 2024 Yahoo. All rights reserved.